Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

SUVmax as a Tool for Differentiating Malignant from Benign Adenopathies on PET/CT Imaging

SUVmax Cutoff Values and Interpretation Considerations

  • The American College of Radiology suggests that the maximum standardized uptake value (SUVmax) is the primary quantitative parameter used to differentiate between malignant and benign adenopathies on PET/CT imaging, with different cutoff values applicable depending on the anatomical location and clinical context 1, 2
  • False-positive results are common in regions with high prevalence of infectious or inflammatory conditions, with specificity as low as 25% in areas of endemic tuberculosis 1, 2

Visual Assessment and Diagnostic Performance

  • Visual interpretation by experienced readers often outperforms strict SUVmax cutoffs alone, with sensitivity of 96-100% and specificity of 76-86% 1, 3
  • The American College of Chest Physicians recommends categorizing PET findings as definitely benign, probably benign, indeterminate, probably malignant, or definitely malignant rather than relying solely on SUVmax values 3, 4

Limitations and Pitfalls

  • False-negative results can occur with certain malignancies that show low metabolic activity, including carcinoid tumors, mucinous adenocarcinomas, and some prostate cancer subtypes 1, 2, 4
  • False-positive results are common with infectious/inflammatory conditions, sarcoidosis, and rheumatoid nodules 1, 2, 4
  • PET/CT cannot reliably differentiate between benign and malignant adnexal lesions, with no clear SUVmax cutoff value established for this purpose 5, 6

Best Practice Recommendations

  • Integrate visual assessment with quantitative SUVmax values for optimal diagnostic accuracy 3, 4
  • Consider the clinical context, including prevalence of inflammatory conditions in the region being evaluated 1, 2